People
Dr. Beall brings both radiology and pain management experience to the SAB.
The layoff leaves 58 percent of FDA employees on the job, which Gottlieb said is higher than the previous shutdown in 2013.
Perlstein’s approach with his start-up, Perlara, is radically different from how most start-ups operate.
Shire will have its new CFO in March.
The agency would have to furlough about 45 percent of its staff.
The new company will focus on developing bispecific antibodies that regulate the immune system.
The company could be hoping the new hire will provide a consultative resource for all health-care regulatory issues.
After a two year absence, Aveo returned to the halls of the key event with a drug newly approved for use in Europe and possibly poised for approval in the U.S.
This not the first time Maraganore has tweeted his support for the benefits of immigration.
The company, which now has 11 personnel, is a CRO focused on infectious disease research.
PRESS RELEASES